The Renaissance system is designed for robotic guidance during spine surgery. Two of the systems were sold in the United States and two were sold in international markets. One of the four buyers also purchased the company's recently-launched brain surgery module. This was the first purchase of the brain surgery module in the United States, a milestone for the company.
"Interest on the part of surgeons to acquire the Renaissance system reached all time highs, and clinical results from the use of our system continue to be outstanding," said Mazor Robotics CEO Ori Hadomi in a news release. "As a result, our system order pipeline remains strong."
Mr. Hadormi also reported the brain application was gaining interest among existing customers. Mazor has been battling the extended administrative approval process for system orders for additional potential customers, but Mr. Hadomi expects to see the additional orders concluded during the second half of the year.
For the first quarter of 2014, Mazor reported the Renaissance surgical guidance system was used to place more than 45,000 implants worldwide. However, the company also reported net loss attributable to ordinary shareholders at $3.6 million and a slightly lower net revenue than the first quarter of 2013.
"Our efforts in the 2014 first quarter yielded a number of positive results," said Mr. Hadomi. "We penetrated two teaching centers which enhanced the awareness of the Renaissance system within the broader academic community. With a total of four systems in hospitals in the state, we believe that Georgia is emerging as a new cluster and will one day complement our success in Florida, Texas and southern California."